Cardamom and Topical Roseomonas for Atopic Dermatitis Relief

This clinical trial is designed to explore a new treatment for atopic dermatitis, a common skin condition often characterized by itchy and inflamed skin. The study focuses on a topical treatment combining Roseomonas mucosa, a type of bacteria, with ground cardamom seeds. This treatment is intended for patients aged 2 and older who suffer from atopic dermatitis. The goal is to see if applying this combination to the skin can effectively reduce symptoms and improve overall skin health, even after stopping the treatment. This research could offer a potential new way to manage atopic dermatitis, especially if it shows lasting benefits and reduces the need for steroid creams. Participants in the study will apply the treatment by mixing a dried product with water and putting it on their skin two to three times a week for 14 weeks. After this period, the treatment will stop, and participants will be monitored for another 14 weeks to see how long any benefits last. The study will evaluate improvements in skin symptoms, like itchiness and rash, and will also look at changes in the skin’s bacterial makeup. Additionally, researchers will assess how easy it is for participants to follow the treatment regimen and whether the treatment reduces the need for other medications. Safety and any side effects will also be closely monitored throughout the study.